- Theranostics
Theranostics is the term used to describe the proposed process of diagnostic therapy for individual patients - to test them for possible reaction to taking a new medication and to tailor a treatment for them based on the test results. [http://www.the-scientist.com/2004/8/30/38/1/]
It encompasses the possible utilisation of a wide range of subjects that includes:
predictive medicine ,personalized medicine ,integrated medicine ,pharmacodiagnostics andDx/Rx partnering This method is looked upon as the possible end result of new advances made in
Pharmacogenomics ,Drug Discovery usingGenetics ,Molecular Biology and Microarray chips technology. [http://www.axis-shield.com/pdfs/Theranostics_flyer.pdf]Etymology
The term was used first by the CEO of PharmaNetics, John Funkhouser. He defined it as, "The ability to affect therapy or treatment of a diseased state."Fact|date=October 2007
References
* Picard FJ, Bergeron MG., Rapid molecular theranostics in infectious diseases, Drug Discov Today. 2002 Nov 1;7(21):1092-101.
* Hooper JW., The genetic map to theranostics, MLO Med Lab Obs. 2006 Jun;38(6):22-3, 25.External links
* [http://www.the-scientist.com/2004/8/30/38/1/ The Scientist 2004, 18(16):38; Published
30 August 2004 ]; PDF documents
* [http://www.axis-shield.com/pdfs/Theranostics_flyer.pdf Axis shield Flyer on this Subject]
Wikimedia Foundation. 2010.
